U.S. markets closed

CryoLife, Inc. (CRY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
28.46-1.29 (-4.34%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close29.75
Open29.58
Bid24.85 x 800
Ask28.65 x 800
Day's Range28.41 - 29.98
52 Week Range16.13 - 32.34
Volume492,463
Avg. Volume217,306
Market Cap1.113B
Beta (5Y Monthly)1.56
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 09, 2015
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • CryoLife (CRY) Soars 24.2%: Is Further Upside Left in the Stock?
    Zacks

    CryoLife (CRY) Soars 24.2%: Is Further Upside Left in the Stock?

    CryoLife (CRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • Cryolife Inc (CRY) Q1 2021 Earnings Call Transcript
    Motley Fool

    Cryolife Inc (CRY) Q1 2021 Earnings Call Transcript

    Joining me from CryoLife's management team are Pat Mackin, CEO; and Ashley Lee, CFO. Comments made on this call that look forward in time involve risks and uncertainties that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

  • CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates
    Zacks

    CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates

    CryoLife (CRY) delivered earnings and revenue surprises of 27.27% and 15.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?